Background:
Bruce Levin, Ph.D., is Professor and Chair of the Department of Biostatistics at Columbia University’s Mailman School of Public Health. Dr. Levin has served as the senior statistical consultant on several multicenter randomized clinical trials in the field of stroke neurology and cardiology, including the WARCEF trial funded by NINDS (Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction), the WARSS trial (Warfarin versus Aspirin in Recurrent Stroke Study), the GAIN Americas trial, and the CABG Patch trial. He serves as the Director of the Statistics, Epidemiology, and Data Management (SED) Core of the HIV Center for Clinical and Behavioral Studies. Dr. Levin has a long-standing interest in statistical methodology for clinical trials, public health, and the law. Using sequential statistical methods, he has published on innovative trial designs, e.g., designs that minimize ethical costs, designs that emphasize the selection paradigm rather than the hypothesis test paradigm, and phase II trials that combine a selection phase with a non-superiority (futility) phase utilizing the same data, such as the QALS trial (high-dose coenzyme Q10 in ALS disease) and the ongoing TNK trial (Tenecteplase versus rt-PA trial for acute stroke).
Dr. Levin is a Fellow of the American Statistical Association. He co-authored the 3rd edition of Statistical Methods for Rates and Proportions with Myunghee Cho Paik and the late Joseph L. Fleiss. Dr. Levin served for ten years as Consulting Statistical Editor for the American Journal of Public Health. He has also served as an expert statistical witness in many court cases, and is co-author with Michael O. Finkelstein of Statistics for Lawyers, now in its second edition. Dr. Levin currently serves on the Oversight Committee for the NINDS Parkinson Disease Neuroprotection Clinical Trials, the Scientific Review Committee for the Parkinsons Study Group, the Huntington’s Study Group, and the Federal Advisory Committee for the National Children’s Study.
Selected publications
